Individual antibody drugs have been developed vigorously, and synchronous drugs have been supported by Formosa Plastics.

Monoclonal antibody drug therapy has the title of "panacea" in the pharmaceutical field because of its strong specificity, high curative effect and few side effects. United biopharmaceutical Co., Ltd., a biopharmaceutical company established in conjunction with Asian biotechnology, is actively developing individual antibody drugs; The company is supported by Formosa Plastics Group. Not only Formosa Plastics Biomedical is its main shareholder, but also Chang Gung Medical System will cooperate with it. There are many monoclonal antibody drugs developed by Synbiotics, including AIDS, herpes simplex virus and anti-vascular endothelial growth factor drugs, among which AIDS drugs are all completed by the company's R&D team; Clinical trials show that single drug therapy can effectively reduce the amount of HIV in AIDS blood by 2.5-3 log 10 (that is, to about11000). As for the use of herpes simplex virus, it is expected to apply for clinical trials of new drugs by the end of this year, and the use of anti-vascular endothelial growth factor is expected to apply for clinical trials of new drugs between 20 15-20 16. In addition, Synbiotics has selected four major monoclonal antibody drugs whose patents are about to expire, and developed similar drugs, including breast cancer monoclonal antibody UB-92 1, rheumatoid arthritis monoclonal antibody UB-72 1, colorectal cancer monoclonal antibody UB-922 and lymphoma monoclonal antibody UB-923. It is expected that in 20 15 years, it will be released. Liansheng Pharmaceutical Co., Ltd. combined the resources of its parent company Lianya Biotechnology and UBI Group, and obtained the investment of Formosa Plastics Group/KLOC-0.2 billion yuan to build a commercial mass-produced protein pharmaceutical factory, and will cooperate with Chang Gung Medical System in research and development and clinic to benefit more patients. Subscribe to the health Aloha audio-visual channel, read health knowledge more easily, and pay attention to your health every day! Line @ ID: @:/supply/article/17103/Single-plant antibody drugs developed vigorously, and Synbiotics was supported by Formosa Plastics. Key words: monoclonal antibody, panacea, Lianya biotechnology, synbiotics, Formosa Plastics, Chang Geng.